Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II

Human Molecular Genetics

Volumn 13, Issue 15, 2004, Pages 1587-1597

  Putt, Wendy ^a   Palmen, Jutta ^a   Nicaud, Viviane ^b   Tregouet, David Alexandre ^b   Tahri Daizadeh, Nadia ^b   Flavell, David M ^a   Humphries, Steve E ^a   Talmud, Philippa J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; GLUCOSE; GUANINE; LIPID; LOW DENSITY LIPOPROTEIN; THYMINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHROMOSOME 1Q; CONTROLLED STUDY; DIET RESTRICTION; ENVIRONMENTAL FACTOR; FAMILIAL HYPERLIPEMIA; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INTERACTION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE HOMEOSTASIS; HAPLOTYPE; HUMAN; INTRON; LIPID METABOLISM; MALE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; CHOLESTEROL, LDL; DNA-BINDING PROTEINS; GLUCOSE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; TRANSCRIPTION FACTORS; UPSTREAM STIMULATORY FACTORS;

EID: 4344641316     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh168     Document Type: Article

References (50)

1. Postic, C., Shiota, M. and Magnuson, M.A. (2001) Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog. Horm. Res., 56, 195-217.
2. Casado, M., Vallet, V.S., Kahn, A. and Vaulont, S. (1999) Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J. Biol. Chem., 274, 2009-2013.
3. Ribeiro, A., Pastier, D., Kardassis, D., Chambaz, J. and Cardot, P. (1999) Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J. Biol. Chem., 274, 1216-1225.
4. Pastier, D., Lacorte, J.M., Chambaz, J., Cardot, P. and Ribeiro, A. (2002) Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4. J. Biol. Chem., 277, 15199-15206.
5. Botma, G., Verhoeven, A.J. and Jansen, H. (2001) Hepatic lipase promoter activity is reduced by the C-480G and G-216A substitutions present in the common LIPC variant and is increased by upstream stimulatory factor. Atherosclerosis, 154, 625-632.
6. Yang, X.P., Freeman, L.A., Knapper, C.L., Amar, M.J., Remaley, A., Brewer, H.B., Jr and Santamarina-Fojo, S. (2002) The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J. Lipid Res., 43, 297-306.
7. Iynedjian, P.B. (1998) Identification of upstream stimulatory factor as transcriptional activator of the liver promoter of the glucokinase gene. Biochem. J., 333, 705-712.
8. Wang, D. and Sul, H.S. (1997) Upstream stimulatory factor binding to the E-box at - 65 is required for insulin regulation of the fatty acid synthase promoter. J. Biol. Chem., 272, 26367-26374.
9. Travers, M.T., Vallance, A.J., Gourlay, H.T., Gill, C.A., Klein, I., Bottema, C.B. and Barber, M.C. (2001) Promoter I of the ovine acetyl-CoA carboxylase-alpha gene: an E-box motif at - 114 in the proximal promoter binds upstream stimulatory factor (USF)-1 and USF-2 and acts as an insulin-response sequence in differentiating adipocytes. Biochem. J., 359, 273-284.
10. Smih, F., Rouet, P., Lucas, S., Mairal, A., Sengenes, C., Lafontan, M., Vaulont, S., Casado, M. and Langin, D. (2002) Transcriptional regulation of adipocyte hormone-sensitive lipase by glucose. Diabetes, 51, 293-300.
11. Read, M.L., Clark, A.R. and Docherty, K. (1993) The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the human insulin gene enhancer. Biochem. J., 295, 233-237.
12. Portois, L., Tastenoy, M., Viollet, B. and Svoboda, M. (2002) Functional analysis of the glucose response element of the rat glucagon receptor gene in insulin-producing INS-1 cells. Biochim. Biophys. Acta, 1574, 175-186.
13. Martin, C.C., Svitek, C.A., Oeser, J.K., Henderson, E., Stein, R. and O'Brien, R.M. (2003) Upstream stimulatory factor (USF) and neurogenic differentiation/beta-cell E-box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression. Biochem. J., 371, 675-686.
14. Vallet, V.S., Casado, M., Henrion, A.A., Bucchini, D., Raymondjean, M., Kahn, A. and Vaulont, S. (1998) Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem., 273, 20 175-201 79.
15. Shieh, B.H., Sparkes, R.S., Gaynor, R.B. and Lusis, A.J. (1993) Localization of the gene-encoding upstream stimulatory factor (USF) to human chromosome 1q22-q23. Genomics, 16, 266-268.
16. Pajukanta, P., Nuotio, I., Terwilliger, J.D., Porkka, K.V., Ylitalo, K., Pihlajamaki, J., Suomalainen, A.J., Syvanen, A.C., Lehtimaki, T., Viikari, J.S. et al. (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat. Genet., 18, 369-373.
17. Coon, H., Myers, R.H., Borecki, I.B., Arnett, D.K., Hunt, S.C., Province, M.A., Djousse, L. and Leppert, M.F. (2000) Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI family heart study. Arterioscler. Thromb. Vasc. Biol., 20, 2275-2280.
18. Vu-Dac, N., Gervois, P., Jakel, H., Nowak, M., Bauge, E., Dehondt, H., Staels, B., Pennacchio, L.A., Rubin, E.M., Fruchart-Najib, J. et al. (2003) Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J. Biol. Chem., 278, 17982-17985.
19. Grundy, S.M., Chait, A. and Brunzell, J.D. (1987) Familial combined hyperlipidemia workshop. Arteriosclerosis, 7, 203-207.
20. Goldstein, J.L., Hazzard, W.R., Schrott, H.G., Bierman, E.L. and Motulsky, A.G. (1973) Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder combined hyperlipidemia. J. Clin. Invest., 52, 1544-1568.
21. Sniderman, A.D., Castro, C.M., Ribalta, J., Carmena, R., de Bruin, T.W., de Graaf, J., Erkelens, D.W., Humphries, S.E., Masana, L., Real, J.T. et al. (2002) A proposal to redefine familial combined hyperlipidaemia - third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur. J. Clin. Invest, 32, 71-73.
22. Seed, M., Mailly, F., Vallance, D., Doherty, E., Winder, A., Talmud, P., Humphries, S.E. and Gudnason, V. (1993) Lipoprotein lipase activity in patients with combined hyperlipidaemia. Clin Invest., 34, 403-415.
23. Tiret, L., Gerdes, C., Murphy, M.J., Dallongeville, J., Nicaud, V., O'Reilly, D.S., Beisiegel, U. and De Backer, G. (2000) Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur. J. Clin. Invest., 30, 578-585.
24. Jansen, H., Waterworth, D.M., Nicaud, V., Ehnholm, C. and Talmud, P.J. (2001) Interaction of the common apolipoprotein C-III (APOC3 -482C>T) and hepatic lipase (LIPC - 514C>T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Ann. Hum. Genet., 65, 237-243.
25. Talmud, P.J., Palmen, J., Nicaud, V. and Tiret, L. (2002) Association of the hormone sensitive lipase - 60C>G variant with fasting insulin levels in healthy young men. Nutr. Metab. Cardiovasc. Dis., 12, 173-177.
26. Waterworth, D.M., Ribalta, J., Nicaud, V., Dallongeville, J., Humphries, S.E. and Talmud, P. (1999) ApoCIII gene variants modulate postprandial. response to both glucose and fat tolerance tests. Circulation, 99, 1872-1877.
27. Tahri-Daizadeh, N., Tregouet, D.A., Nicaud, V., Manuel, N., Cambien, F. and Tiret, L. (2003) Automated detection of informative combined effects in genetic association studies of complex traits. Genome Res., 13, 1952-1960.
28. Pajukanta, P., Lilja, H.E., Sinsheimer, J.S., Cantor, R.M., Lusis, A.J., Gentile, M., Dua, X.J., Soro-Paavonene, A., Naukkarinen, J. et al. (2004) Familial combined hyperlipidemia is associated with upstream trasncription factor 1 (USF1). Nat. Genet., 36, 371-376.
29. Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S.T., Manolescu, A., Jonsdottir, S., Jonsdottir, T., Gudmundsdottir, T., Bjarnadottir, S.M., Einarsson, O.B., Gudjonsdottir, H.M. et al. (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet., 35, 131-138.
30. Saito, T., Oishi, T., Yanai, K., Shimamoto, Y. and Fukamizu, A. (2003) Cloning and characterization of a novel splicing isoform. of USF1. Int. J. Mol. Med., 12, 161-167.
31. Allayee, H., Aouizerat, B.E., Cantor, R.M., Dallinga Thie, G.M., Krauss, R.M., Lanning, C.D., Rotter, J.I., Lusis, A.J. and de Bruin, T.W. (1998) Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet., 63, 577-585.
32. Fisher, R.M., Mailly, F., Peacock, R.E., Hamsten, A., Seed, M., Yudkin, J.S., Beisiegel, U., Feussner, G., Miller, G., Humphries, S.E. et al. (1995) Interaction of the lipoprotein lipase asparagine 291 > serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidaemic subjects, myocardial infarction survivors and healthy adults. J. Lipid Res., 36, 2104-2112.
33. Veerkamp, M.J., de Graaf, J., Bredie, S.J., Hendriks, J.C., Demacker, P.N. and Stalenhoef, A.F. (2002) Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler. Thromb. Vasc. Biol., 22, 274-282.
34. Talmud, P.J., Palmen, J. and Walker, M. (1998) Identification of genetic variation in the human hormone-sensitive lipase gene and 5′ sequences: homology of 5′ sequences with mouse promoter and identification of potential regulatory elements. Biochem. Biophys. Res. Commun., 252, 661-668.
35. Talmud, P.J., Palmen, J., Luan, J., Flavell, D., Byrne, C.D., Waterworth, D.M. and Wareham, N.J. (2001) Variation in the promoter of the human hormone sensitive lipase gene shows gender specific effects on insulin and lipid levels: regults from the Ely study. Biochim. Biophys. Acta, 1537, 239-244.
36. Pihlajamaki, J., Valve, R., Karjalainene, L., Karhapia, P. and Laakso, M. (2001) The hormone sentive lipase gene in familial combined hyperlipidemia and insulin resistance. Eur. J. Clin. Invest., 31, 302-308.
37. Wang, C.S., McConathy, W.J., Kloer, H.U. and Alaupovic, P. (1985) Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest., 75, 384-390.
38. Aalto Setala, K., Fisher, E.A., Chen, X., Chajek Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H.N. and Breslow, J.L. (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J. Clin. Invest., 90, 1889-1900.
39. Li, W.W., Dammerman, M.M., Smith, J.D., Metzger, S., Breslow, J.L. and Leff, T. (1995) Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest., 96, 2601-2605.
40. Waterworth, D.M., Talmud, P.J., Luan, J., Flavell, D.M., Byrne, C.D., Humphries, S.E. and Wareham, N.J. (2003) Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim. Biophys. Acta, 1637, 200-206.
41. Groenendijk, M., Cantor, R.M., de Bruin, T.W. and Dallinga-Thie, G.M. (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis, 157, 1-11.
42. Elbein, S.C., Hoffman, M.D., Teng, K., Leppert, M.F. and Hasstedt, S.J. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes, 48, 1175-1182.
43. Day, I.N.M. and Humphries, S.E. (1994) Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem., 222, 389-395.
44. Nei, M. (1987) Molecular Evolutionary Genetics. Columbia University Press, New York.
45. Tiret, L., Amouyel, P., Rakotovao, R., Cambien, F. and Ducimetiere, P. (1991) Testing for association between disease and linked marker loci: a log-linear-model analysis. Am. J. Hum. Genet., 48, 926-934,
46. Rothman, K.J. (1990) No adjustments are needed for multiple comparisons. Epidemiology, 1, 43-46.
47. Perneger, T.V. (1999) Adjusting for multiple testing in studies is less important than other concerns. Br. Med. J., 318, 1288.
48. Perneger, T.V. (1998) What's wrong with Bonferroni adjustments. Br. Med. J., 316, 1236-1238.
49. Tregouet, D.A., Barbaux, S., Escolano, S., Tahri, N., Golmard, J.L., Tiret, L. and Cambien, F. (2002) Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet., 11, 2015-2023.
50. Tregouet, D.A., Ricard, S., Nicaud, V., Arnould, L, Soubigou, S., Rosier, M., Duverger, N., Poirier, O., Mace, S., Kee, F. et al. (2004) In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 24, 775-781.